• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪代谢障碍综合征:抗逆转录病毒疗法对HIV感染的形态学和代谢影响

Lipodystrophy syndrome: the morphologic and metabolic effects of antiretroviral therapy in HIV infection.

作者信息

Norris Angela, Dreher H Michael

机构信息

Partnership Comprehensive Care Practice HIV Clinic, Drexel University, Philadelphia, PA, USA.

出版信息

J Assoc Nurses AIDS Care. 2004 Nov-Dec;15(6):46-64. doi: 10.1177/1055329004271187.

DOI:10.1177/1055329004271187
PMID:15538016
Abstract

Widespread use of highly active antiretroviral therapy (HAART) to manage HIV infection is now associated with the development of lipodystrophy syndrome. This syndrome is a combination of such morphologic and metabolic changes as hyperlipidemia, fat redistribution, and insulin resistance. Although many of the long-term effects of HAART have not been fully recognized, it is thought that lipodystrophy syndrome may now contribute to early-onset hypercholesterolemia, heart disease, and diabetes, and may have a negative psychological impact on the individual living with HIV infection.

摘要

目前,广泛使用高效抗逆转录病毒疗法(HAART)治疗HIV感染与脂肪代谢障碍综合征的发生有关。该综合征是高脂血症、脂肪重新分布和胰岛素抵抗等形态学和代谢变化的组合。尽管HAART的许多长期影响尚未得到充分认识,但人们认为脂肪代谢障碍综合征现在可能导致早发性高胆固醇血症、心脏病和糖尿病,并且可能对感染HIV的个体产生负面心理影响。

相似文献

1
Lipodystrophy syndrome: the morphologic and metabolic effects of antiretroviral therapy in HIV infection.脂肪代谢障碍综合征:抗逆转录病毒疗法对HIV感染的形态学和代谢影响
J Assoc Nurses AIDS Care. 2004 Nov-Dec;15(6):46-64. doi: 10.1177/1055329004271187.
2
Cardiovascular risk and body-fat abnormalities in HIV-infected adults.HIV感染成人的心血管风险与体脂异常
N Engl J Med. 2005 Jan 6;352(1):48-62. doi: 10.1056/NEJMra041811.
3
Metabolic effects of protease inhibitor therapy.蛋白酶抑制剂疗法的代谢效应。
AIDS Read. 1999 Jul;9(4):254-6, 259-60, 266-9.
4
Current concepts of metabolic abnormalities in HIV patients: focus on lipodystrophy.
AIDS Read. 2003 Dec;13(12 Suppl):S5-13.
5
Clinical review 159: Human immunodeficiency virus/highly active antiretroviral therapy-associated metabolic syndrome: clinical presentation, pathophysiology, and therapeutic strategies.临床综述159:人类免疫缺陷病毒/高效抗逆转录病毒治疗相关代谢综合征:临床表现、病理生理学及治疗策略
J Clin Endocrinol Metab. 2003 May;88(5):1961-76. doi: 10.1210/jc.2002-021704.
6
Lipodystrophy, insulin resistance, diabetes mellitus, dyslipidemia, and cardiovascular disease in human immunodeficiency virus infection.人类免疫缺陷病毒感染中的脂肪营养不良、胰岛素抵抗、糖尿病、血脂异常和心血管疾病。
South Med J. 2003 Feb;96(2):180-8; quiz 189. doi: 10.1097/01.SMJ.0000051731.69719.2E.
7
[Lipodystrophy and lipid metabolism alterations in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].接受高效抗逆转录病毒疗法(HAART)的HIV感染患者的脂肪代谢障碍和脂质代谢改变
Recenti Prog Med. 2004 May;95(5):265-75.
8
HIV-associated lipodystrophy syndrome.人类免疫缺陷病毒相关脂肪代谢障碍综合征
Coll Antropol. 2006 Dec;30 Suppl 2:59-62.
9
Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study.在乌干达,接受高效抗逆转录病毒疗法的感染艾滋病毒的儿童和青少年中的脂肪营养不良:一项横断面研究。
J Int AIDS Soc. 2012 Jul 2;15(2):17427. doi: 10.7448/IAS.15.2.17427.
10
Update on HIV/HAART associated morphologic and metabolic abnormalities.
Forum Nutr. 2003;56:158-62.

引用本文的文献

1
The Role of HIV Infection in the Pathophysiology of Gestational Diabetes Mellitus and Hypertensive Disorders of Pregnancy.HIV感染在妊娠期糖尿病和妊娠高血压疾病病理生理学中的作用。
Front Cardiovasc Med. 2021 May 12;8:613930. doi: 10.3389/fcvm.2021.613930. eCollection 2021.
2
Cardiometabolic disease risk and HIV status in rural South Africa: establishing a baseline.南非农村地区的心脏代谢疾病风险与艾滋病毒感染状况:建立基线
BMC Public Health. 2015 Feb 12;15:135. doi: 10.1186/s12889-015-1467-1.
3
Understanding diabetes in patients with HIV/AIDS.
了解 HIV/AIDS 患者中的糖尿病。
Diabetol Metab Syndr. 2011 Jan 14;3(1):2. doi: 10.1186/1758-5996-3-2.